Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates

[1]  Gail M. Williams,et al.  Efficacy of an 11-Valent Pneumococcal Conjugate Vaccine Against Radiologically Confirmed Pneumonia Among Children Less Than 2 Years of Age in the Philippines: A Randomized, Double-Blind, Placebo-Controlled Trial , 2009, The Pediatric infectious disease journal.

[2]  J. Scott,et al.  Enhanced diagnosis of pneumococcal meningitis with use of the Binax NOW immunochromatographic test of Streptococcus pneumoniae antigen: a multisite study. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  K. O'Brien,et al.  Global literature review of Haemophilus influenzae type b and Streptococcus pneumoniae invasive disease among children less than five years of age 1980-2005 , 2009 .

[4]  R. Ulloa-Gutierrez,et al.  6th International Symposium on Pneumococci and Pneumococcal Diseases , 2008, Expert review of vaccines.

[5]  Igor Rudan,et al.  Epidemiology and etiology of childhood pneumonia. , 2008, Bulletin of the World Health Organization.

[6]  Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008. , 2008, MMWR. Morbidity and mortality weekly report.

[7]  K. O'Brien,et al.  The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. , 2008, The Lancet. Infectious diseases.

[8]  A. Naheed,et al.  Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. , 2007, The American journal of tropical medicine and hygiene.

[9]  Des Anticorps.  Pneumococcal conjugate vaccine for childhood immunization--WHO position paper. , 2007, Releve epidemiologique hebdomadaire.

[10]  F. Hoz,et al.  The Burden of Pneumococcal Disease and Cost-Effectiveness of a Pneumococcal Vaccine in Latin America and the Caribbean A Review of the Evidence and a Preliminary Economic Analysis , 2007 .

[11]  T. Cherian,et al.  Effectiveness of Heptavalent Pneumococcal Conjugate Vaccine in Children Younger Than 5 Years of Age for Prevention of Pneumonia: Updated Analysis Using World Health Organization Standardized Interpretation of Chest Radiographs , 2006, The Pediatric infectious disease journal.

[12]  T. Cherian,et al.  Pneumococcal vaccination in developing countries , 2006, The Lancet.

[13]  S. Cousens,et al.  Estimating the causes of 4 million neonatal deaths in the year 2000. , 2006, International journal of epidemiology.

[14]  Samina S Farooqi,et al.  The World Health Report 2005 - Make Every Mother and Child Count , 2005, Annals of Saudi Medicine.

[15]  K. Shibuya,et al.  Health statistics: time to get serious. , 2005, Bulletin of the World Health Organization.

[16]  J. Spencer-Jones,et al.  Make every mother and child count. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[17]  J. Carlin,et al.  Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. , 2005, Bulletin of the World Health Organization.

[18]  Robert E Black,et al.  WHO estimates of the causes of death in children , 2005, The Lancet.

[19]  S. Obaro,et al.  Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.

[20]  S. Cousens,et al.  4 million neonatal deaths: When? Where? Why? , 2005, The Lancet.

[21]  K. Maitland,et al.  Bacteremia among children admitted to a rural hospital in Kenya. , 2005, The New England journal of medicine.

[22]  Joy E. Lawn,et al.  4 million neonatal deaths: When? Where? Why? Neonatal survival 1. , 2005 .

[23]  Zoe Matthews,et al.  The World Health Report 2005 - make every mother and child count , 2005 .

[24]  B. Gessner,et al.  Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Robert E Black,et al.  Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems. , 2003, International journal of epidemiology.

[26]  S. Madhi,et al.  A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. , 2003, The New England journal of medicine.

[27]  U. Högberg,et al.  The World Health report 2002. , 2003, Midwifery.

[28]  E. Lewis,et al.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia , 2002, The Pediatric infectious disease journal.

[29]  Nu.  Road map towards the implementation of the United Nations Millennium Declaration: report of the Secretary-General , 2002 .

[30]  C. Dye,et al.  Estimates of world-wide distribution of child deaths from acute respiratory infections. , 2002, The Lancet. Infectious diseases.

[31]  J. Carlin,et al.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.

[32]  K. Mulholland.  Strategies for the control of pneumococcal diseases. , 1999, Vaccine.

[33]  R. Yolken,et al.  PCR-Enzyme Immunoassay for Detection ofStreptococcus pneumoniae DNA in Cerebrospinal Fluid Samples from Patients With Culture-Negative Meningitis , 1998, Journal of Clinical Microbiology.

[34]  A. Traoré,et al.  Méningites à Haemophilus influenzae à Bobo-Dioulasso (Burkina Faso) , 1992 .

[35]  A. Parant.  [World population prospects]. , 1990, Futuribles.

[36]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[37]  A. Bernard-Bonnin,et al.  [Purulent meningitis in children in Yaoundé: epidemiological and prognostic aspects]. , 1985, Annales de la Societe belge de medecine tropicale.

[38]  M. Hilleman,et al.  Pneumococcal Vaccines , 1978, The Lancet.